Alzheimer’s disease is a progressive brain disorder that gradually destroys a person's memory and ability to learn, reason, make judgments, communicate, and carry out daily activities. As Alzheimer’s progresses, individuals may also experience changes in personality and behavior, such as anxiety, suspiciousness or agitation, as well as delusions or hallucinations. Although there is currently no cure for Alzheimer’s, new treatments are on the horizon as a result of accelerating insight into the biology of the disease. Research has also shown that effective care and support can improve quality of life for individuals and their caregivers over the course of the disease from diagnosis to the end of life.
News items related to the topic: Alzheimer's disease
Investigational new drug for Alzheimer’s scheduled for first study in humans
Vanderbilt University scientists have received notification from the U.S. Food and Drug Administration (FDA) that testing in humans may proceed for an investigational new drug for Alzheimer’s disease after more than 10 years of research by scientists at Vanderbilt University and Vanderbilt University Medical Center.
People related to the topic: Alzheimer's disease
Fiona Harrison, Ph.D.
Assistant Professor, Division of Diabetes, Endocrinology & Metabolism; Associate Director, IDDRC Neuroscience Core D; Mouse Behavioral Phenotyping Facility Faculty Coordinator, IDDRC Neuroscience Core D
Angela Jefferson, Ph.D.
Professor of Neurology and Medicine
James May, M.D.
Professor of Medicine; Professor of Molecular Physiology and Biophysics
Paul Newhouse, M.D.
Jim Turner Professor of Cognitive Disorders;
Professor of Psychiatry & Behavioral Sciences, Pharmacology, and Medicine; Director, Vanderbilt Center for Cognitive Medicine; Program Director, Vanderbilt-TVHS Geriatric Psychiatry Fellowship;
Physician-Scientist, VA-TVHS GRECC
Back to the topic index